Publication | Closed Access

In vivo neuronal gene editing via CRISPR–Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer’s disease

Neurodegenerative DiseasesAlzheimer's DiseaseCrispr–cas9 Amphiphilic NanocomplexesVivo Neuronal GeneMedicineDegenerative PathologyGene EditingGenome EditingNeuroscienceNeurodegenerationAlzheimer ’CrisprBiomolecular Engineering